PMID: 2104921Jan 1, 1990Paper

Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

The Journal of Experimental Medicine
A N ShakhovC V Jongeneel

Abstract

We have explored the cis-acting elements necessary for the LPS-mediated activation of the mouse TNF-alpha promoter by transfecting a set of 5' deletion mutants linked to the CAT reporter gene into primary bone marrow-derived macrophages. A major drop in inducibility by LPS was seen upon deletion of a region mapping between nt -655 and nt -451. Gel retardation assays revealed that LPS induced the appearance in this region of several specific DNA-protein complexes mapping to sequence motifs with strong homology to the kappa B enhancer. Constructs containing two or more copies of one of the kappa B enhancer motifs linked to a heterologous promoter were inducible by LPS. Additional deletion of a region between nt -301 and nt -241, which contains a MHC class II-like "Y box" and formed a Y box-specific complex with a protein whose concentration was increased by LPS, caused a nearly complete loss of inducibility by LPS. We speculate that NF-kappa B and/or related proteins are involved in the LPS-induced transcriptional activation of the TNF-alpha gene, and that factors interacting with the Y box can additionally modulate the activity of the gene in macrophages.

References

Jul 1, 1989·The Journal of Experimental Medicine·J S EconomouD L Morton
Mar 1, 1989·European Journal of Immunology·C V JongeneelJ C Cerottini
Jan 1, 1988·Annual Review of Biochemistry·B Beutler, A Cerami
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A DornD Mathis
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M Sakurai, J L Strominger
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M F ShannonM A Vadas
Nov 1, 1988·The Journal of Experimental Medicine·S S SungS M Fu
Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·D V GoeddelB J Sugarman
Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·S A NedospasovN S Bystrov

❮ Previous
Next ❯

Citations

Jun 26, 1999·European Journal of Immunology·P LauzuricaJ M Redondo
Aug 1, 1992·Journal of Cellular Physiology·J R BetheaE N Benveniste
Dec 4, 1998·Springer Seminars in Immunopathology·T HasunumaK Nishioka
Jan 1, 1991·Immunologic Research·D R Johnson, J S Pober
Jul 26, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Sanjay BatraMalaya K Sahoo
Apr 1, 1996·Pflügers Archiv : European journal of physiology·S FredeW Jelkmann
Dec 17, 2010·Journal of Mammary Gland Biology and Neoplasia·Stephen L Shiao, Lisa M Coussens
Oct 1, 2001·Journal of the American Aging Association·H J KwonH Y Chung
Jan 30, 2013·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Hui Yu
Aug 29, 1996·European Journal of Pharmacology·C D McWhinneyC K Edwards
Sep 1, 1994·Pharmacology & Therapeutics·Y Ohmori, T A Hamilton
Sep 15, 1993·Gene·S TakashibaT E Van Dyke
Dec 1, 1990·The Journal of Nutritional Biochemistry·E S FoxS A Broitman
Jun 4, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H TakatsunaK Umezawa
Feb 7, 1997·Biochemical Pharmacology·S Legrand-PoelsJ Piette
Jul 31, 2003·The Journal of Surgical Research·Daniel R MeldrumAlden H Harken

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.